Efficacy and safety associated with immune checkpoint inhibitors in unresectable hepatocellular carcinoma: A re-analysis of a meta-analysis

被引：0
|
作者：
Zhou, Shouhao [1 ,2 ,4 ]
Shen, Chan [1 ,2 ,3 ]
机构：
[1] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA
[2] Penn State Univ, Penn State Canc Inst, Hershey, PA 17033 USA
[3] Penn State Univ, Coll Med, Dept Surg, Hershey, PA 17033 USA
[4] Penn State Univ, Dept Publ Hlth Sci, 90 Hope Dr,ASB 3400L, Hershey, PA 17033 USA
来源：
JGH OPEN | 2023年 / 7卷 / 02期
关键词：
Bayesian statistics; immune checkpoint inhibitors; meta-analysis; predictive intervals; unresectable hepatocellular carcinoma;
D O I：
10.1002/jgh3.12856
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
We identified analytic limitations in a recent meta-analysis and re-examined the efficacy and safety associated with immune checkpoint inhibitors (ICIs) in unresectable hepatocellular carcinoma (HCC) compared with standard therapies. Our findings mostly contradict conclusions from the previous study, suggesting the need for continuing the investigation of ICIs in HCC with additional clinical evidence.
引用
收藏
页码：163 / 164
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety Associated With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma A Meta-analysis
    Jacome, Alexandre A.
    Castro, Ana Carolina G.
    Vasconcelos, Joao Paulo S.
    Silva, Maria Helena C. R.
    Lessa, Marco Antonio O.
    Moraes, Eduardo D.
    Andrade, Aline C.
    Lima, Frederico M. T.
    Farias, Joao Paulo F.
    Gil, Roberto A.
    Prolla, Gabriel
    Garicochea, Bernardo
    JAMA NETWORK OPEN, 2021, 4 (12) : E2136128
  • [2] Comparison of Efficacy and Safety between Immune Checkpoint Inhibitors and Targeted Drugs in Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Su, Chenguang
    Liao, Zheng
    Wang, Zixiang
    Pei, Yinxuan
    Li, Weiwei
    Liu, Jinlong
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024,
  • [3] Efficacy and safety of immune checkpoint inhibitors combined anti-angiogenic therapy in patients with unresectable hepatocellular carcinoma: A meta-analysis
    Xian, Feng
    Wu, Cailiang
    Zhang, Guojun
    Xu, Guohui
    MEDICINE, 2022, 101 (44) : E31479
  • [4] Efficacy and safety of immune checkpoint inhibitors (ICIs) in unresectable hepatocellular carcinoma (HCC): A systematic review and meta-analysis of randomized clinical trials (RCTs).
    Jacome, Alexandre A.
    Guimaraes De Castro, Ana Carolina
    Solar Vasconcelos, Joao Paulo
    Cruz Rangel Silva, Maria Helena
    Oliveira Lessa, Marco Antonio
    de Moraes, Eduardo Dias
    Andrade, Aline Chaves
    Figueiredo Ferreira, Barbara Sodre
    Lima, Frederico M. T.
    Bulcao, Marcela Lima
    Ferreira, Artur Rodrigues
    Fogacci De Farias, Joao Paulo
    Prolla, Gabriel
    Garicochea, Bernardo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis
    Lei, Qing
    Yan, Xin
    Zou, Huimin
    Jiang, Yixuan
    Lai, Yunfeng
    Ung, Carolina Oi Lam
    Hu, Hao
    DISCOVER ONCOLOGY, 2022, 13 (01)
  • [6] Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis
    Qing Lei
    Xin Yan
    Huimin Zou
    Yixuan Jiang
    Yunfeng Lai
    Carolina Oi Lam Ung
    Hao Hu
    Discover Oncology, 13
  • [7] The Efficacy and Safety of Immune Checkpoint Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis
    Ababneh, Obada
    Ghazou, Alina
    Alawajneh, Mohmmad
    Alhaj Mohammad, Saleh
    Bani-Hani, Abdullah
    Alrabadi, Nasr
    Shreenivas, Aditya
    CANCERS, 2024, 16 (05)
  • [8] Meta-analysis of the efficiency and safety of neoadjuvant therapy with immune checkpoint inhibitors in resectable hepatocellular carcinoma
    Tuersun, Adili
    Yasen, Yadikaer
    Mohetaer, Munire
    Hou, Guanxin
    Cheng, Gang
    Zhao, Xin
    FRONTIERS IN MEDICINE, 2025, 11
  • [9] Comparative efficacy and safety of immune checkpoint inhibitors for unresectable advanced melanoma: A systematic review and network meta-analysis
    Li, Yan
    Liang, Xueyan
    Li, Huijuan
    Chen, Xiaoyu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 115
  • [10] Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis
    Dolladille, Charles
    Akroun, Julia
    Morice, Pierre-Marie
    Dompmartin, Anne
    Ezine, Emilien
    Sassier, Marion
    Da-Silva, Angelique
    Plane, Anne-Flore
    Legallois, Damien
    L'orphelin, Jean-Mathieu
    Alexandre, Joachim
    EUROPEAN HEART JOURNAL, 2021, 42 (48) : 4964 - +
12345